| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $5.10B | $4.79B | $4.15B | $3.77B | $3.77B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $371.00M | $343.00M | $324.00M | $307.00M | $271.00M |
| SG&A | $2.23B | $2.08B | $1.74B | $1.48B | $1.39B |
| Operating Income | $113.00M | $162.00M | $130.00M | $207.00M | $329.00M |
| Interest Expense | $421.00M | $399.00M | $283.00M | $146.00M | $0.00 |
| Tax Expense | $35.00M | $71.00M | $82.00M | $58.00M | $125.00M |
| Net Income | -$360.00M | -$317.00M | -$260.00M | $6.00M | $182.00M |
| EPS (basic) | -1.0200 | -0.9000 | -0.7400 | 0.0200 | 0.5200 |
| EPS (diluted) | -1.0200 | -0.9000 | -0.7400 | 0.0200 | 0.5200 |
| Shares (diluted) | $353.80M | $351.80M | $350.50M | $350.20M | $350.00M |